Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Progressive matrix stiffening of tyramine-modified silk fibroin hydrogels governs stage-specific pulmonary fibroblast activation.

bioRxiv : the preprint server for biology·2026
Same author

Modeling ventricular tachycardia in genetic long QT syndrome using engineered cardiac tissues.

Bioactive materials·2026
Same author

Human iPSC-derived macrophages for studying intrinsic and extrinsic factors in cystic fibrosis.

EXO : beyond the cell·2026
Same author

A Simple, Robust Method for Cellular Electrical Interfacing Using Molecular Patterning.

ACS applied materials & interfaces·2026
Same author

Impact of prior SARS-CoV-2 acquisition on binding and neutralizing antibody responses following COVID-19 vaccination: A cross-protocol analysis of individual-level data from six phase 3 clinical trials.

Vaccine·2026
Same author

Avenues for optimization of cardiac therapeutics by minimally invasive delivery.

Acta biomaterialia·2026

Related Experiment Video

Updated: Mar 9, 2026

Modeling Primary Bone Tumors and Bone Metastasis with Solid Tumor Graft Implantation into Bone
06:53

Modeling Primary Bone Tumors and Bone Metastasis with Solid Tumor Graft Implantation into Bone

Published on: September 9, 2020

3.3K

Tissue-Engineered Model of Human Osteolytic Bone Tumor.

Aranzazu Villasante1, Alessandro Marturano-Kruik1,2, Samuel T Robinson1

  • 11 Department of Biomedical Engineering, Columbia University , New York, New York.

Tissue Engineering. Part C, Methods
|January 11, 2017
PubMed
Summary

Researchers developed a novel bioengineered bone model to study Ewing sarcoma (ES) osteolysis. This model effectively recapitulates tumor-induced bone destruction, aiding in the development of new therapies for this pediatric cancer.

Keywords:
Ewing's sarcomaosteoclastsosteolysistissue engineeringtumor model

More Related Videos

Three-Dimensional Bone Extracellular Matrix Model for Osteosarcoma
08:07

Three-Dimensional Bone Extracellular Matrix Model for Osteosarcoma

Published on: April 12, 2019

7.7K
Author Spotlight: Replicating Human Osteosarcoma Progression in Immunodeficient Mice for Cancer Study
02:35

Author Spotlight: Replicating Human Osteosarcoma Progression in Immunodeficient Mice for Cancer Study

Published on: March 22, 2024

1.6K

Related Experiment Videos

Last Updated: Mar 9, 2026

Modeling Primary Bone Tumors and Bone Metastasis with Solid Tumor Graft Implantation into Bone
06:53

Modeling Primary Bone Tumors and Bone Metastasis with Solid Tumor Graft Implantation into Bone

Published on: September 9, 2020

3.3K
Three-Dimensional Bone Extracellular Matrix Model for Osteosarcoma
08:07

Three-Dimensional Bone Extracellular Matrix Model for Osteosarcoma

Published on: April 12, 2019

7.7K
Author Spotlight: Replicating Human Osteosarcoma Progression in Immunodeficient Mice for Cancer Study
02:35

Author Spotlight: Replicating Human Osteosarcoma Progression in Immunodeficient Mice for Cancer Study

Published on: March 22, 2024

1.6K

Area of Science:

  • Biomedical Engineering
  • Oncology
  • Skeletal Biology

Background:

  • Ewing sarcoma (ES) is an aggressive pediatric bone cancer known for metastasis.
  • Tumor cells induce osteoclast activity, causing bone lesions, pain, and hypercalcemia.
  • Current models struggle to replicate ES-induced osteolysis, hindering therapeutic development.

Purpose of the Study:

  • To develop a novel, controllable bioengineered model of human bone that incorporates Ewing sarcoma.
  • To enable quantitative studies of tumor-bone interactions and osteolytic processes.
  • To facilitate the testing of therapeutic agents against ES-induced bone destruction.

Main Methods:

  • Engineered human bone constructs with osteoblasts and osteoclasts in a 3D mineralized matrix.
  • Introduction of ES cell aggregates into the engineered bone microenvironment.
  • Assessment of bone density, connectivity, matrix deposition, and therapeutic agent efficacy.

Main Results:

  • The engineered bone model demonstrated normal bone remodeling with osteoclast resorption and osteoblast formation.
  • ES cell introduction led to decreased bone density, connectivity, and matrix deposition.
  • Zoledronic acid, a known therapeutic, effectively inhibited osteoclast-mediated bone resorption in the model.

Conclusions:

  • The novel bioengineered bone model accurately recapitulates Ewing sarcoma-induced osteolysis.
  • This model provides a platform for studying tumor-bone interactions and evaluating therapeutic strategies.
  • The model shows promise for advancing the understanding and treatment of Ewing sarcoma metastasis.